# Accretion Nutraveda Ltd (ANL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹272
Day Change: +4.21%
52W High: ₹300
52W Low: ₹150.1
Market Cap: ₹197 Cr

## Valuation
P/E: 75.14
P/B: 4.55
EPS: ₹3.62
Book Value: ₹59.77
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 100%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Accretion Nutraveda Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Accretion Nutraveda Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Updates On Acquisition
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Data Freshness
Quote Updated: 2026-05-17T03:24:38.350Z
Price History Updated: 2026-05-18T22:59:38.759Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-18T22:59:38.759Z
Quant Updated: 2026-05-18T22:59:38.759Z
Sentiment Updated: 2026-05-18T22:59:38.759Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2023)
Revenue: ₹3 Cr
Operating Profit: ₹0 Cr (OPM 16.42%)
Net Profit: ₹0 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2023: Rev ₹3Cr | PAT ₹0Cr | OPM 16.42%
FY 2024: Rev ₹5Cr | PAT ₹1Cr | OPM 23%
FY 2025: Rev ₹16Cr | PAT ₹3Cr | OPM 22.05%

## Balance Sheet (FY 2023)
Total Assets: ₹4 Cr
Total Liabilities: ₹4 Cr
Borrowings: ₹2 Cr
Cash: ₹undefined Cr

---
Source: rupiya.io/stocks/anl
Disclaimer: For research and education only. Not investment advice.